Disposition of 455 shares by Jason Adair of Liquidia Technologies at 11.51 subject to Rule 16b-3

LQDA Stock  USD 15.96  0.22  1.40%   
About 58% of Liquidia Technologies' investor base is looking to short. The analysis of overall sentiment of trading Liquidia Technologies stock suggests that many investors are alarmed at this time. The current market sentiment, together with Liquidia Technologies' historical and current headlines, can help investors time the market. In addition, many technical investors use Liquidia Technologies stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Liquidia Technologies Officer: Chief Business Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 455 common stock at 11.51 of Liquidia Technologies by Jason Adair on 2nd of December 2024. This event was filed by Liquidia Technologies with SEC on 2024-12-02. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Liquidia Technologies' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Liquidia Technologies' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Liquidia Technologies Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Liquidia Technologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Liquidia Technologies Maximum Pain Price Across April 17th 2025 Option Contracts

Liquidia Technologies' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Liquidia Technologies close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Liquidia Technologies' options.

Liquidia Technologies Fundamental Analysis

We analyze Liquidia Technologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Liquidia Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Liquidia Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

Liquidia Technologies is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Liquidia Technologies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Liquidia Technologies stock to make a market-neutral strategy. Peer analysis of Liquidia Technologies could also be used in its relative valuation, which is a method of valuing Liquidia Technologies by comparing valuation metrics with similar companies.

Peers

Liquidia Technologies Related Equities

NRXPNRX Pharmaceuticals   11.97   
0%
100.0%
LYRALyra Therapeutics   5.56   
0%
46.0%
TERNTerns Pharmaceuticals   3.10   
0%
25.0%
AMLXAmylyx Pharmaceuticals   1.63   
0%
13.0%
NVCTNuvectis Pharma   1.26   
0%
10.0%
BMRNBiomarin Pharmaceutical   0.23   
0%
1.0%
UTHRUnited Therapeutics   0.12   
1.0%
0%
TECHBio Techne   0.32   
2.0%
0%
PCVXVaxcyte   0.36   
3.0%
0%
KRONKronos Bio   1.00   
8.0%
0%
INZYInozyme Pharma   1.32   
11.0%
0%
REPLReplimune   1.33   
11.0%
0%
MIRMMirum Pharmaceuticals   2.01   
16.0%
0%
IMCRImmunocore Holdings   2.03   
16.0%
0%
KALVKalvista Pharmaceuticals   2.83   
23.0%
0%
GERNGeron   2.98   
24.0%
0%
GOSSGossamer Bio   3.48   
29.0%
0%
AGENAgenus   4.10   
34.0%
0%
LEGNLegend Biotech   4.40   
36.0%
0%
ABOSAcumen Pharmaceuticals   4.55   
38.0%
0%
LRMRLarimar Therapeutics   6.02   
50.0%
0%
XFORX4 Pharmaceuticals   11.29   
94.0%
0%

Complementary Tools for Liquidia Stock analysis

When running Liquidia Technologies' price analysis, check to measure Liquidia Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Liquidia Technologies is operating at the current time. Most of Liquidia Technologies' value examination focuses on studying past and present price action to predict the probability of Liquidia Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Liquidia Technologies' price. Additionally, you may evaluate how the addition of Liquidia Technologies to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Insider Screener
Find insiders across different sectors to evaluate their impact on performance